Compare Nuvalent Inc (NUVL) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Verizon Communications Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Verizon Communications Inc trades at $43.73 (market cap $181.64B). The key difference: Verizon Communications Inc is far larger — about 18.5× Nuvalent Inc's market cap, and Verizon Communications Inc pays a 6.51% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | VZ | |
|---|---|---|
Market Cap | $9.81B | $181.64B |
Sector | Technology | Media |
52-Week High | $123.96 | $51.38 |
52-Week Low | $72.16 | $38.40 |
Enterprise Value | $8.52B | $369.14B |
Volume | — | 22,584,735 |
Dividend Yield | — | 6.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Verizon (VZ) trades at $43.78, up 0.44% today, with a bearish technical signal but strong fundamentals including a P/E of 10.61 and consistent earnings beats. Recent news highlights a restructuring involving 3,000 job cuts and the sale of 274 stores to franchisees, aimed at boosting efficiency ahead of Q2 2026 earnings. Cash flow improved in 2025 with net cash flow of $14.9 billion, supporting its 6.5% dividend yield.
Outlook: Attractive for income investors due to stable cash flows and high dividend, but faces risks from 5G competition and margin pressure. Analyst consensus price target is $47.83, suggesting upside potential if execution improves. Key risks include debt levels and industry discounts threatening profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
